Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Catalytic inhibitor of Protein Phosphatase 5 activates the extrinsic apoptotic pathway by disrupting complex II in kidney cancer.
Ahanin EF, Sager RA, Backe SJ, Dunn DM, Dushukyan N, Blanden AR, Mate NA, Suzuki T, Anderson T, Roy M, Oberoi J, Prodromou C, Nsouli I, Daneshvar M, Bratslavsky G, Woodford MR, Bourboulia D, Chisholm JD, Mollapour M. Ahanin EF, et al. Among authors: nsouli i. Cell Chem Biol. 2023 Oct 19;30(10):1223-1234.e12. doi: 10.1016/j.chembiol.2023.06.026. Epub 2023 Jul 31. Cell Chem Biol. 2023. PMID: 37527661
In Vivo Models for Prostate Cancer Research.
Adamiecki R, Hryniewicz-Jankowska A, Ortiz MA, Li X, Porter-Hansen BA, Nsouli I, Bratslavsky G, Kotula L. Adamiecki R, et al. Among authors: nsouli i. Cancers (Basel). 2022 Oct 28;14(21):5321. doi: 10.3390/cancers14215321. Cancers (Basel). 2022. PMID: 36358740 Free PMC article. Review.
Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma.
Sager RA, Backe SJ, Ahanin E, Smith G, Nsouli I, Woodford MR, Bratslavsky G, Bourboulia D, Mollapour M. Sager RA, et al. Among authors: nsouli i. Nat Rev Urol. 2022 May;19(5):305-320. doi: 10.1038/s41585-022-00571-8. Epub 2022 Mar 9. Nat Rev Urol. 2022. PMID: 35264774 Free PMC article. Review.
Percutaneous Bladder Catheterization (Suprapubic Bladder Catheterization).
Okafor HT, Nsouli IS. Okafor HT, et al. Among authors: nsouli is. Atlas Oral Maxillofac Surg Clin North Am. 2015 Sep;23(2):177-81. doi: 10.1016/j.cxom.2015.05.008. Epub 2015 Jul 2. Atlas Oral Maxillofac Surg Clin North Am. 2015. PMID: 26333906 Review. No abstract available.
Reply: To PMID 25623666.
Byler TK, Reeder JE, Nsouli I, Bratslavsky G. Byler TK, et al. Among authors: nsouli i. Urology. 2015 Feb;85(2):291. doi: 10.1016/j.urology.2014.09.050. Urology. 2015. PMID: 25623668 No abstract available.
Radical prostatectomy versus observation for localized prostate cancer.
Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Gingrich JR, Wei JT, Gilhooly P, Grob BM, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Sharifi R, Blank W, Pandya P, Andriole GL, Culkin D, Wheeler T; Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group. Wilt TJ, et al. Among authors: nsouli i. N Engl J Med. 2012 Jul 19;367(3):203-13. doi: 10.1056/NEJMoa1113162. N Engl J Med. 2012. PMID: 22808955 Free PMC article. Clinical Trial.
Basal cell carcinoma of the prostate: a case report.
Stearns G, Cheng JS, Shapiro O, Nsouli I. Stearns G, et al. Among authors: nsouli i. Urology. 2012 Jun;79(6):e79-80. doi: 10.1016/j.urology.2012.03.003. Urology. 2012. PMID: 22656427
The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ, Brawer MK, Barry MJ, Jones KM, Kwon Y, Gingrich JR, Aronson WJ, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Fox S. Wilt TJ, et al. Among authors: nsouli i. Contemp Clin Trials. 2009 Jan;30(1):81-7. doi: 10.1016/j.cct.2008.08.002. Epub 2008 Aug 23. Contemp Clin Trials. 2009. PMID: 18783735 Clinical Trial.
18 results